Adriana Ribas Andrade

10PUBLICATIONS
82CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)Cardiology (incl. cardiovascular diseases)Electrochemical energy storage and conversion
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Oct 16, 2025
Real-World Effectiveness and Safety of Golimumab in Patients with Ulcerative Colitis: A Retrospective Cohort Study.

Rodrigo Galhardi Gasparini, Carlos Taxonera, Antônio José Tibúrcio Alves Júnior

|Jul 18, 2025
Linking histological healing to quality of life: real-world insights into golimumab therapy in ulcerative colitis.

Rodrigo Galhardi Gasparini, Carlos Taxonera, Antônio José Tibúrcio Alves Júnior

|Feb 21, 2024
Clinical factors associated with severity in patients with inflammatory bowel disease in Brazil based on 2-year national registry data from GEDIIB.

Renata de Sá Brito Fróes, Adriana Ribas Andrade, Mikaell Alexandre Gouvea Faria

|Oct 20, 2023
Vedolizumab in Mild-to-Moderate Crohn's Disease Patients Naïve to Biological Therapy: A Multicentric Observational Study.

Adriana Zanoni Dotti, Daniela Oliveira Magro, Eduardo Garcia Vilela

|Mar 30, 2023
SECOND BRAZILIAN CONSENSUS ON THE MANAGEMENT OF CROHN'S DISEASE IN ADULTS: A CONSENSUS OF THE BRAZILIAN ORGANIZATION FOR CROHN'S DISEASE AND COLITIS (GEDIIB).

Marcello Imbrizi, Júlio Pinheiro Baima, Matheus Freitas Cardoso de Azevedo

Pageof 2